Skip to main content

Baker Bros Boosts RYTM Stake to 10.9%

October 10, 2022

The most significant insider activity on today’s list is a 13G filed by Baker Bros Advisors LP.

The hedge fund revealed an increase in ownership from 7.7% to 10.9% in the small-cap biotechnology company Rhythm Pharmaceuticals $RYTM.

This is the largest follow-up purchase Baker Bros has reported since revealing the original position back in 2017.

Baker Bros is now the second-largest shareholder in RYTM.

In another Form 4, Turtle Creek Asset Management reported a purchase of $2.2 million in JELD-WEN Holding $JELD.

Here’s The Hot List, with data through October 7, 2022:

Roivant Sciences Ltd revealed the acquisition of $2.5 million in shares of Immunovant $IMVT.

Two directors for the small-cap REIT Armada Hoffler Properties reported insider buys in a pair of Form 4 filings.

Over in Washington, Senator Richard Blumenthal of Connecticut reported a position in APi Group Corporation $APG.

The only stock that saw bullish options flow was the memory and hard drive manufacturer Western Digital Corporation $WDC.

Stay tuned. We'll be back Tuesday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team